Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.5301 EUR
−14.94 M EUR
0.00 EUR
27.96 M
About FibroBiologics, Inc.
Sector
Industry
CEO
Peter O'Heeron
Website
Headquarters
Houston
Founded
2021
FIGI
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Related stocks
Frequently Asked Questions
The current price of A3EP67 is 1.2300 EUR — it has decreased by −21.66% in the past 24 hours. Watch FibroBiologics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LS exchange FibroBiologics, Inc. stocks are traded under the ticker A3EP67.
A3EP67 stock hasn't changed in a week, the month change is a −19.08% fall, over the last year FibroBiologics, Inc. has showed a −19.08% decrease.
We've gathered analysts' opinions on FibroBiologics, Inc. future price: according to them, A3EP67 price has a max estimate of 15.42 EUR and a min estimate of 11.57 EUR. Watch A3EP67 chart and read a more detailed FibroBiologics, Inc. stock forecast: see what analysts think of FibroBiologics, Inc. and suggest that you do with its stocks.
A3EP67 reached its all-time high on Jan 30, 2025 with the price of 1.5700 EUR, and its all-time low was 1.2300 EUR and was reached on Feb 14, 2025. View more price dynamics on A3EP67 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
A3EP67 stock is 27.64% volatile and has beta coefficient of 0.95. Track FibroBiologics, Inc. stock price on the chart and check out the list of the most volatile stocks — is FibroBiologics, Inc. there?
Today FibroBiologics, Inc. has the market capitalization of 37.30 M, it has decreased by −31.55% over the last week.
Yes, you can track FibroBiologics, Inc. financials in yearly and quarterly reports right on TradingView.
FibroBiologics, Inc. is going to release the next earnings report on May 28, 2025. Keep track of upcoming events with our Earnings Calendar.
A3EP67 earnings for the last quarter are −0.10 EUR per share, whereas the estimation was −0.09 EUR resulting in a −8.70% surprise. The estimated earnings for the next quarter are −0.08 EUR per share. See more details about FibroBiologics, Inc. earnings.
FibroBiologics, Inc. revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
A3EP67 net income for the last quarter is −449.07 K EUR, while the quarter before that showed 838.37 K EUR of net income which accounts for −153.56% change. Track more FibroBiologics, Inc. financial stats to get the full picture.
No, A3EP67 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 11, 2025, the company has 10.00 employees. See our rating of the largest employees — is FibroBiologics, Inc. on this list?
Like other stocks, A3EP67 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FibroBiologics, Inc. stock right from TradingView charts — choose your broker and connect to your account.